Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis

Clinical trial NCT01255592 · COMPLETED

Trial details

NCT number: NCT01255592
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchiectasis Lung Disease Respiratory Diseases

Start date: 2011-02-01
Primary completion: 2012-02-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.